Autotaxin Promotes the Expression of Matrix Metalloproteinase-3 via Activation of the MAPK Cascade in Human Fibrosarcoma HT-1080 Cells

REFERENCES

• Ferry G., Tellier E., Try A., Gres S., Naime I., Simon M. F., Rodriguez M., Boucher J., Tack I., Gesta S., Chomarat P., Dieu M., Raes M., Galizzi J. P., Valet P., Boutin J. A., Saulnier-Blache J. S. Autotaxin is released from adipocytes, catalyzes lysophosphatidic acid synthesis, and activates preadipocyte proliferation. Up-regulated expression with adipocyte differentiation and obesity. J. Biol. Chem. 2003; 278: 18162–18169
   PubMed Web of Science ®Google Scholar
• Stracke M. L., Liotta L. A., Schiffmann E. The role of autotaxin and other motility stimulating factors in the regulation of tumor cell motility. Symp. Soc. Exp. Biol. 1993; 47: 197–214
   PubMedGoogle Scholar
• Nam S. W., Clair T., Campo C. K., Lee H. Y., Liotta L. A., Stracke M. L. Autotaxin (ATX), a potent tumor motogen, augments invasive and metastatic potential of ras-transformed cells. Oncogene 2000; 19: 241–247
   PubMed Web of Science ®Google Scholar
• Lee H. Y., Bae G. U., Jung I. D., Lee J. S., Kim Y. K., Noh S. H., Stracke M. L., Park C. G., Lee H. W., Han J. W. Autotaxin promotes motility via G protein-coupled phosphoinositide 3-kinase gamma in human melanoma cells. FEBS Lett. 2002; 515: 137–140
   PubMed Web of Science ®Google Scholar
• Jung I. D., Lee J., Yun S. Y., Park C. G., Choi W. S., Lee H. W., Choi O. H., Han J. W., Lee H. Y. Cdc42 and Rac1 are necessary for autotaxin-induced tumor cell motility in A2058 melanoma cells. FEBS Lett. 2002; 532: 351–356
   PubMed Web of Science ®Google Scholar
• Song J., Clair T., Noh J. H., Eun J. W., Ryu S. Y., Lee S. N., Ahn Y. M., Kim S. Y., Lee S. H., Park W. S., Yoo N. J., Lee J. Y., Nam S. W. Autotaxin (lysoPLD/NPP2) protects fibroblasts from apoptosis through its enzymatic product, lysophosphatidic acid, utilizing albumin-bound substrate. Biochem. Biophys. Res. Commun. 2005; 337: 967–975
   PubMed Web of Science ®Google Scholar
• Nam S. W., Clair T., Kim Y. S., McMarlin A., Schiffmann E., Liotta L. A., Stracke M. L. Autotaxin (NPP-2), a metastasis-enhancing motogen, is an angiogenic factor. Cancer Res. 2001; 61: 6938–6944
   PubMed Web of Science ®Google Scholar
• van Meeteren L. A., Ruurs P., Stortelers C., Bouwman P., van Rooijen M. A., Pradère J. P., Pettit T. R., Wakelam M. J., Saulnier-Blache J. S., Mummery C. L., Moolenaar W. H., Jonkers J. Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during development. Mol. Cell. Biol. 2006; 26: 5015–5022
   PubMed Web of Science ®Google Scholar
• Umezu-Goto M., Kishi Y., Taira A., Hama K., Dohmae N., Takio K., Yamori T., Mills G. B., Inoue K., Aoki J., Arai H. Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production. J. Cell. Biol. 2002; 158: 227–233
   PubMed Web of Science ®Google Scholar
• Gerrard J. M., Clawson C. C., White J. G. Lysophosphatidic acids: III. Enhancement of neutrophil chemotaxis. Am. J. Pathol. 1980; 100: 609–618
   Web of Science ®Google Scholar
• Jalink K., Moolenaar W. H., Van Duijn, Lysophosphatidic B. acid is a chemoattractant for Dictyostelium discoideum amoebae. Proc. Natl. Acad. Sci. USA 1993; 90: 1857–1861
   PubMed Web of Science ®Google Scholar
• Satoh Y., Ohkawa R., Nakamura K., Higashi K., Kaneko M., Yokota H., Aoki J., Arai H., Yuasa Y., Yatomi Y. Lysophosphatidic acid protection against apoptosis in the human pre-B-cell line Nalm-6. Eur. J. Haematol. 2007; 78: 510–517
   PubMed Web of Science ®Google Scholar
• Hu Y. L., Tee M. K., Goetzl E. J., Auersperg N., Mills G. B., Ferrara N., Jaffe R. B. Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells. J. Natl. Cancer Inst. 2001; 93: 762–768
   PubMed Web of Science ®Google Scholar
• Sako A., Kitayama J., Shida D., Suzuki R., Sakai T., Ohta H., Nagawa H. Lysophosphatidic acid (LPA)-induced vascular endothelial growth factor (VEGF) by mesothelial cells and quantification of host-derived VEGF in malignant ascites. J. Surg. Res. 2006; 130: 94–101
   PubMed Web of Science ®Google Scholar
• Xu Y., Shen Z., Wiper D. W., Wu M., Morton R. E., Elson P., Kennedy A. W., Belinson J., Markman M., Casey G. Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers. JAMA 1998; 280: 719–723
   PubMed Web of Science ®Google Scholar
• Seckl M. J., Seufferlein T., Rozengurt E. Lysophosphatidic acid-depleted serum, hepatocyte growth factor and stem cell growth factor stimulate colony growth of small cell lung cancer cells through a calcium-independent pathway. Cancer Res. 1994; 54: 6143–6147
   PubMed Web of Science ®Google Scholar
• Tigyi G., Miledi R. Lysophosphatidates bound to serum albumin activate membrane currents in Xenopus oocytes and neurite retraction in PC12 phenochromocytoma cells. J. Biol. Chem. 1992; 267: 21360–21367
   PubMed Web of Science ®Google Scholar
• Xu Y., Gaudette D. C., Boynton J. D., Frankel A., Fang X. J., Sharma A., Hurteau J., Casey G., Goodbody A., Mellors A. Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients. Clin. Cancer Res. 1995; 1: 1223–1232
   PubMed Web of Science ®Google Scholar
• Moolenaar W. H. Bioactive lysophospholipids and their G protein-coupled receptors. Exp Cell Res 1999; 253: 230–238
   PubMed Web of Science ®Google Scholar
• Wojciak-Stothard B., Ridley A. J. Rho GTPases and the regulation of endothelial permeability. Vascul. Pharmacol. 2002; 39: 187–199
   PubMed Web of Science ®Google Scholar
• Ye X., Ishii I., Kingsbury M. A., Chun J. Lysophosphatidic acid as a novel cell survival/apoptotic factor. Biochim. Biophys. Acta. 2002; 1585: 108–113
   PubMed Web of Science ®Google Scholar
• van Leeuwen F.N., Giepmans B. N., van Meeteren L. A., Moolenaar W. H. Lysophosphatidic acid: mitogen and motility factor. Biochem. Soc. Trans. 2003; 31: 1209–1212
   PubMed Web of Science ®Google Scholar
• Radeff-Huang J., Seasholtz T. M., Matteo R. G., Brown J. H. G protein mediated signaling pathways in lysophospholipid induced cell proliferation and survival. J. Cell. Biochem. 2004; 92: 949–966
   PubMed Web of Science ®Google Scholar
• Moolenaar W. H., van Meeteren L. A., Giepmans B. N. The ins and outs of lysophosphatidic acid signaling. Bioessays 2004; 26: 870–881
   PubMed Web of Science ®Google Scholar
• Saatian B., Zhao Y., He D., Georas S. N., Watkins T., Spannhake E. W., Natarajan V. Transcriptional regulation of lysophosphatidic acid-induced interleukin-8 expression and secretion by p38 MAPK and JNK in human bronchial epithelial cells. Biochem. J. 2006; 393: 657–668
   PubMed Web of Science ®Google Scholar
• Woessner J. F. Jr. Matrix metalloproteinases and the inhibitors in connective tissue remodeling. FASEB J. 1991; 5: 2145–2154
   Google Scholar
• Matrisian L. M. The matrix-degrading metalloproteinases. Bioassays 1992; 14: 455–463
   PubMed Web of Science ®Google Scholar
• Butticè G., Duterque-Coquillaud M., Basuyaux J. P., Carrère S., Kurkinen M., Stéhelin D. Erg, an Ets-family member, differentially regulates human collagenase1 (MMP1) and stromelysin1 (MMP3) gene expression by physically interacting with the Fos/Jun complex. Oncogene 1996; 13: 2297–2306
   PubMed Web of Science ®Google Scholar
• Biondi M. L., Turri O., Leviti S., Seminati R., Cecchini F., Bernini M., Ghilardi G., Guagnellini E. MMP1 and MMP3 polymorphisms in promoter regions and cancer. Clin. Chem. 2000; 46: 2023–2024
   PubMed Web of Science ®Google Scholar
• Kusukawa J., Harada H., Shima I., Sasaguri Y., Kameyama T., Morimatsu M. The significance of epidermal growth factor receptor and matrix metalloproteinase-3 in squamous cell carcinoma of the oral cavity. Eur. J. Cancer Oral. Oncol. 1996; 32B: 217–221
   PubMed Web of Science ®Google Scholar
• Eum S.-Y., Lee Y.-W., Hennig B., Toborek M. Interplay between epidermal growth factor receptor and janus kinase 3 regulates polychlorinated biphenyl-Induced matrix metalloproteinase-3 expression and transendothelial migration of tumor Cells. Mol. Cancer Res. 2006; 4: 361–370
   PubMed Web of Science ®Google Scholar
• MacNaul K. L., Chartrain N., Lark M., Tocci M. J., Hutchinson N. I. Discoordinate expression of stromelysin, collagenase, and tissue inhibitor of metalloproteinases-1 in rheumatoid human synovial fibroblasts. J. Biol. Chem. 1990; 265: 17238–17245
   PubMed Web of Science ®Google Scholar
• Behera A. K., Thorpe C. M., Kidder J. M., Smith W., Hildebrand E., Hu L. T. Borrelia burgdorferi-Induced expression of matrix metalloproteinases from human chondrocytes requires mitogen-activated protein kinase and janus kinase/signal transducer and activator of transcription signaling pathways. Infect. Immun. 2004; 72: 2864–2871
   PubMed Web of Science ®Google Scholar
• Park C.-H., Lee M. J., Ahn J., Kim S., Kim H. H., Kim K. H., Eun H. C., Chung J. H. Heat shock-induced matrix metalloproteinase (MMP)-1 and MMP-3 are mediated through ERK and JNK activation and via an autocrine interleukin-6 loop. J. Invest Dermatol. 2004; 123: 1012–1019
   PubMed Web of Science ®Google Scholar
• Sweeney S. E., Hammaker D., Boyle D. L., Firestein G. S. Regulation of c-Jun phosphorylation by the IkB kinase-£complex in fibroblast-like synoviocytes. J. Immunol. 2005; 174: 6424–6430
   PubMed Web of Science ®Google Scholar
• Inoue T., Hammaker D., Boyle D. L., Firestein G. S. Regulation of JNK by MKK-7 in fibroblast-like synoviocytes. Arthritis Rheum. 2006; 54: 2127–2135
   PubMed Web of Science ®Google Scholar
• Haga A., Hashimoto K., Tanaka N., Nakamura K. T., Deyashiki Y. Scalable purification and characterization of the extracellular domain of human autotaxin from prokaryotic cells. Protein Expr. Purif. 2008; 59: 9–17
   PubMed Web of Science ®Google Scholar
• van Meeteren L. A., Ruurs P., Christodoulou E., Goding J. W., Takakusa H., Kikuchi K., Perrakis A., Nagano T., Moolenaar W. H. Inhibition of autotaxin by lysophosphatidic acid and sphingosine 1-phosphate. J. Biol. Chem. 2005; 280: 21155–21161
   PubMed Web of Science ®Google Scholar
• Clair T., Koh E., Ptaszynska M., Bandle R. W., Liotta L. A., Schiffmann E., Stracke M. L. PMC L-histidine inhibits production of lysophosphatidic acid by the tumor-associated cytokine, autotaxin. Lipids Health Dis. 2005; 5: 1–18
   Google Scholar
• Smyth S. S., Sciorra V. A., Sigal Y. J., Pamuklar Z., Wang Z., Xu Y., Prestwich G. D., Morris A. J. Lipid phosphate phosphatases regulate lysophosphatidic acid production and signaling in platelets: studies using chemical inhibitors of lipid phosphate phosphatase activity. J. Biol. Chem. 2003; 278: 43214–43223
   PubMed Web of Science ®Google Scholar
• Cui P., Tomsig J. L., McCalmont W. F., Lee S., Becker C. J., Lynch K. R., Macdonald T. L. Synthesis and biological evaluation of phosphonate derivatives as autotaxin (ATX) inhibitors. Bioorg. Med. Chem. Lett. 2007; 17: 1634–1640
   PubMed Web of Science ®Google Scholar
• Achterberg V., Gercken G. Metabolism of ether lysophospholipids in Leishmania donovani promastigotes. Mol. Biochem. Parasitol. 1987; 26: 277–287
   PubMed Web of Science ®Google Scholar
• Kawasaki T., Snyde F. The metabolism of lyso-platelet-activating factor (1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine) by a calcium-dependent lysophospholipase D in rabbit kidney medulla. Biochim. Biophys. Acta. 1987; 920: 85–93
   PubMed Web of Science ®Google Scholar
• Gijsbers R., Aoki J., Arai H., Bollen M. The hydrolysis of lysophospholipids and nucleotides by autotaxin (NPP2) involves a single catalytic site. FEBS Lett. 2003; 538: 60–64
   PubMed Web of Science ®Google Scholar
• Zalatan J. G., Fenn T. D., Brunger A. T., Herschlag D. Structural and functional comparisons of nucleotide pyrophosphatase/phosphodiesterase and alkaline phosphatase: implications for mechanism and evolution. Biochemistry 2006; 45: 9788–9803
   PubMed Web of Science ®Google Scholar
• Zhao Y., He D., Saatian B., Watkins T., Spannhake E. W., Pyne N. J., Natarajan V. Regulation of lysophosphatidic acid-induced epidermal growth factor receptor transactivation and interleukin-8 secretion in human bronchial epithelial cells by protein kinase C, Lyn kinase, and matrix metalloproteinases. J. Biol. Chem. 2006; 281: 19501–19511
   PubMed Web of Science ®Google Scholar
• Deng T., Karin M. c-Fos transcriptional activity stimulated by H-Ras-activated protein kinase distinct from JNK and ERK. Nature 1994; 371: 171–175
   PubMed Web of Science ®Google Scholar
• Monje P., Marinissen M. J., Gutkind J. S. Phosphorylation of the carboxyl-terminal transactivation domain of c-Fos by extracellular signal-regulated kinase mediates the transcriptional activation of AP-1 and cellular transformation induced by platelet-derived growth factor. Mol. Cell. Biol. 2003; 23: 7030–7043
   PubMed Web of Science ®Google Scholar
• Shah B. H., Baukal A. J., Shah F. B., Catt K. J. Mechanisms of extracellularly regulated kinases 1/2 activation in adrenal glomerulosa cells by lysophosphatidic acid and epidermal growth factor. Mol. Endocrinol. 2005; 19: 2535–2548
   PubMed Web of Science ®Google Scholar
• Nishida E., Gotoh Y., The M AP. kinase cascade is essential for diverse signal transduction pathways. Trends Biochem. Sci. 1993; 18: 128–131
   PubMed Web of Science ®Google Scholar
• Ip Y. T., Davis R. J. Signal transduction by the c-Jun N-terminal kinase (JNK)-from unflammation to development. Curr. Opin. Cell. Biol. 1998; 10: 205–219
   PubMed Web of Science ®Google Scholar
• Sambucetti L. C., Curren T. The Fos protein complex is associated with DNA in isolated nuclei and binds to DNA cellulose. Science 1986; 234: 1417–1419
   PubMed Web of Science ®Google Scholar
• Distel R. J., Ro H. S., Rosen B. S., Groves D. L., Spiegelman B. M. Nucleoprotein complexes that regulate gene expression in adipocyte differentiation: direct participation of c-Fos. Cell 1987; 49: 835–844
   PubMed Web of Science ®Google Scholar
• Bhomann D., Bos T. J., Admon A., Nishimura T., Vogt P. K., Tjian R. Human proto-oncogene c-jun encodes a DNA binding protein with structural and functional properties of transcription factor AP-1. Science 1987; 238: 1386–1392
   PubMed Web of Science ®Google Scholar
• Jeon E. S., Song H. Y., Kim M. R., Moon H. J., Bae Y. C., Jung J. S., Kim J. H. Sphingosylphosphorylcholine induces proliferation of human adipose tissue-derived mesenchymal stem cells via activation of JNK. J. Lipid Res. 2006; 47: 653–664
   PubMed Web of Science ®Google Scholar
• Lee Y. J., Shukla S. D. Pro- and anti-apoptotic roles of c-Jun N-terminal kinase (JNK) in ethanol and acetaldehyde exposed rat hepatocytes. Eur. J. Pharmacol. 2005; 31: 31–45
   Google Scholar
• Korhonen R., Linker K., Pautz A., Förstermann U., Moilanen E., Kleinert H. Post-transcriptional regulation of human inducible nitric-oxide synthase expression by the Jun N-terminal kinase. Mol. Pharmacol. 2007; 71: 1427–1434
   PubMed Web of Science ®Google Scholar
• Gaire M., Magbanua Z., McDonnell S., McNeil L., Lovett D. H., Matrisian L. M. Structure and expression of the human gene for the matrix metalloproteinase matrilysin. J. Biol. Chem. 1994; 269: 2032–2040
   PubMed Web of Science ®Google Scholar
• Sato H., Seiki M. Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene 1993; 8: 395–405
   PubMed Web of Science ®Google Scholar
• Uría J.A., Jiménez M. G., Balbín M., Freije J. M., López-Otín C. Differential effects of transforming growth factor-beta on the expression of collagenase-1 and collagenase-3 in human fibroblasts. J. Biol. Chem. 1998; 273: 9769–9777
   PubMed Web of Science ®Google Scholar
• Stracke M. L., Krutzsch H. C., Unsworth E. J., Arestad A., Cioce V., Schiffmann E., Liotta L. A. Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein. J. Biol. Chem. 1992; 267: 2524–2529
   PubMed Web of Science ®Google Scholar
• Murata J., Lee H. Y., Clair T., Krutzsch H. C., Arestad A. A., Sobel M. E., Liotta L. A., Stracke M. L. cDNA cloning of the human tumor motility-stimulating protein, autotaxin, reveals a homology with phosphodiesterases. J. Biol. Chem. 1994; 269: 30479–30484
   PubMed Web of Science ®Google Scholar
• Clair T., Lee H. Y., Liotta L. A., Stracke M. L. Autotaxin is an exoenzyme possessing 5′ -nucleotide phosphodiesterase/ATP pyrophosphatase and ATPase activities,. Biol J. Chem. 1997; 271: 996–1001
   Google Scholar